ストックスクリーナーアプリを入手
20.94
2.20%
-0.43
前日終値:
$21.37
開ける：
$21.6
24時間の取引高:
375.57K
Relative Volume:
0.08
時価総額：
$5.01B
収益：
$330.24M
当期純損益:
$34.79M
株価収益率:
-104.70
EPS:
-0.2
ネットキャッシュフロー:
$66.12M
1週間 パフォーマンス:
+3.47%
1か月 パフォーマンス:
+33.80%
6か月 パフォーマンス:
+117.71%
1年 パフォーマンス:
+430.46%
1日の値動き範囲:
$20.87
$21.70
1週間の範囲:
$18.90
$21.70
52週間の値動き範囲:
$3.60
$23.64
Adma Biologics Inc Stock (ADMA) Company Profile
ADMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| ADMA | 20.91 | 5.01B | 330.24M | 34.79M | 66.12M | -0.20 |
| VRTX | 446.78 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.30 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 586.52 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.35 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.55 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-07-19 | 再開されました | Raymond James | Strong Buy |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2021-11-11 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 開始されました | Jefferies | Buy |
| 2019-04-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-07 | 再開されました | H.C. Wainwright | Buy |
| 2017-12-11 | 繰り返されました | Maxim Group | Buy |
| 2017-11-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | アップグレード | Maxim Group | Hold → Buy |
| 2016-08-01 | ダウングレード | Maxim Group | Buy → Hold |
| 2016-07-25 | 繰り返されました | Maxim Group | Buy |
| 2015-05-13 | 繰り返されました | Maxim Group | Buy |
| 2014-12-08 | 開始されました | Oppenheimer | Outperform |
| 2014-12-01 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Adma Biologics Inc (ADMA) 最新ニュース
ADMA Biologics drops as auditor resigns - MSN
New Millennium Group LLC Acquires New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
First Turn Management LLC Acquires New Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - PR Newswire
Wall Street Analysts See a 31.3% Upside in Adma Biologics (ADMA): Can the Stock Really Move This High? - Yahoo Finance
Oppenheimer & Co. Inc. Has $1.90 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
GSA Capital Partners LLP Sells 109,045 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - Zacks Investment Research
Statutory Profit Doesn't Reflect How Good ADMA Biologics' (NASDAQ:ADMA) Earnings Are - Yahoo Finance
Entropy Technologies LP Purchases Shares of 37,850 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
State of New Jersey Common Pension Fund D Has $2.27 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Janney Montgomery Scott LLC Takes Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
29,143 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Acquired by Aigen Investment Management LP - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Stake Raised by Amalgamated Bank - MarketBeat
Principal Financial Group Inc. Has $23.87 Million Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Los Angeles Capital Management LLC Acquires 67,740 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
ADMA Biologics Inc (ADMA) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Mesirow Financial Investment Management Inc. Sells 30,105 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Stock Traders Buy Large Volume of ADMA Biologics Call Options (NASDAQ:ADMA) - MarketBeat
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Yahoo Finance
Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance
Lisanti Capital Growth LLC Takes $4.70 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
HC Wainwright Predicts Increased Earnings for ADMA Biologics - MarketBeat
HC Wainwright Issues Positive Forecast for ADMA Biologics (NASDAQ:ADMA) Stock Price - MarketBeat
Earnings Beat: Here's What ADMA Biologics, Inc. (NASDAQ:ADMA) Analysts Are Forecasting For Next Year - Yahoo Finance
ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2024 Earnings Call Transcript - Insider Monkey
Kirby McInerney LLP Reminds ADMA Biologics, Inc. (ADMA) Investors of Shareholder Investigation - WICZ
Robeco Institutional Asset Management B.V. Purchases 68,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
New York State Teachers Retirement System Purchases New Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Earnings call: ADMA Biologics reports robust growth, raises guidance - Investing.com India
ADMA Biologics stock soars to all-time high of $21.25 By Investing.com - Investing.com South Africa
ADMA Biologics (NASDAQ:ADMA) Stock Price Expected to Rise, Raymond James Analyst Says - MarketBeat
ADMA Biologics (NASDAQ:ADMA) Reaches New 52-Week HighWhat's Next? - MarketBeat
ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
ADMA Biologics stock soars to all-time high of $21.25 - Investing.com
ADMA INVESTOR NEWS: ADMA Biologics Investors with Losses - GlobeNewswire
Adma Biologics: Q3 Earnings Snapshot - CTPost
ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Reco - GuruFocus.com
ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Record Revenue and Net Income Surge - Yahoo Finance
ADMA Biologics, Inc. Revises Earnings Guidance for the Fiscal Year 2024-2025 - Marketscreener.com
ADMA Biologics Reports Robust Q3 2024 Growth - TipRanks
ADMA Biologics Inc earnings beat by $0.02, revenue topped estimates - Investing.com
ADMA Biologics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance UK
ADMA Biologics Inc Reports Q3 2024 Revenue of $119.8 Million, Su - GuruFocus.com
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Did ADMA Biologics (ADMA) Commit Securities Fraud Resulting in 20% Stock Drop? Contact BFA Law about its Ongoing Investigation - AccessWire
3 High Growth Tech Stocks Leading The US Market - Yahoo Finance
ADMA STOCK ALERT: Why is ADMA Biologics Under Investigation for Securities Fraud? Contact BFA Law if You Lost Money on Your Investment (Nasdaq:ADMA) - AccessWire
ADMA Biologics Inc (ADMA) Q3 2024: Everything You Need To Know A - GuruFocus.com
Adma Biologics Inc (ADMA) 財務データ
収益
当期純利益
現金流量
EPS
0.42%
0.16%
大文字化:
|
ボリューム (24 時間):